Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
19 Setembro 2023 - 8:00AM
Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage
biopharmaceutical company focused on developing small molecules to
restore neuronal health and slow neurodegeneration, today announced
that Company management will participate in a panel presentation at
the 2023 Cantor Fitzgerald Global Healthcare Conference taking
place from September 26-28, 2023 in New York City. Details are as
follows:
2023 Cantor Fitzgerald Global Healthcare
Conference Panel Presentation Date and Time: Tuesday,
September 26, 2023, from 10:30 am – 11:00 am ETLocation:
InterContinental Barclay Hotel
A live webcast of the panel presentation can be accessed from
the Investors section of the Athira website at
https://investors.athira.com/news-and-events/events-and-presentations-investor.
An archived replay of the webcasts will be available for at least
30 days following the event.
About Athira Pharma, Inc.Athira Pharma, Inc.,
headquartered in the Seattle, Washington area, is a late
clinical-stage biopharmaceutical company focused on developing
small molecules to restore neuronal health and slow
neurodegeneration. Athira aims to alter the course of neurological
disease by advancing its pipeline of therapeutic candidates
targeting the HGF/MET neurotrophic system for Alzheimer’s and
Parkinson’s disease, Dementia with Lewy bodies, and amyotrophic
lateral sclerosis. For more information, visit www.athira.com.
You can also follow Athira on Facebook, LinkedIn and
@athirapharma on X, formerly known
as Twitter, and Instagram.
Investor & Media Contact:
Julie RathbunAthira
PharmaJulie.rathbun@athira.com206-769-9219
Athira Pharma (NASDAQ:ATHA)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Athira Pharma (NASDAQ:ATHA)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024